Department of Orthopaedic Surgery, Johns Hopkins University, Baltimore, MD.
Department of Orthopaedic Surgery, Columbia University Medical Center, New York, NY.
J Pediatr Orthop. 2023 Sep 1;43(8):e657-e668. doi: 10.1097/BPO.0000000000002464. Epub 2023 Jul 10.
Surgical site infection (SSI) is a major potential complication following pediatric spinal deformity surgery that is associated with significant morbidity and increased costs. Despite this, SSI rates remain high and variable across institutions, in part due to a lack of up-to-date, comprehensive prevention, and treatment protocols. Furthermore, few attempts have been made to review the optimal diagnostic modalities and treatment strategies for SSI following scoliosis surgery. The aim of this study was to systematically review current literature on risk factors for SSI in pediatric patients undergoing scoliosis surgery, as well as strategies for prevention, diagnosis, and treatment.
On January 19, 2022, a systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies reporting risk factors for acute, deep SSI (<90 d) or strategies for prevention, diagnosis, or treatment of SSI following pediatric scoliosis surgery were included. Each included article was assigned a level of evidence rating based on study design and quality. Extracted findings were organized into risk factors, preventive strategies, diagnostic modalities, and treatment options and each piece of evidence was graded based on quality, quantity, and consistency of underlying data.
A total of 77 studies met the inclusion criteria and were included in this systematic review, of which 2 were categorized as Level I, 3 as Level II, 64 as Level III, and 8 as Level IV. From these studies, a total of 29 pieces of evidence (grade C or higher) regarding SSI risk factors, prevention, diagnosis, or treatment were synthesized.
We present an updated review of published evidence for defining high-risk patients and preventing, diagnosing, and treating SSI after pediatric scoliosis surgery. The collated evidence presented herein may help limit variability in practice and decrease the incidence of SSI in pediatric spine surgery.
Level III-systematic review.
手术部位感染(SSI)是小儿脊柱畸形手术后的一种主要潜在并发症,与显著的发病率增加和成本增加有关。尽管如此,SSI 的发生率仍然很高,并且在不同的机构之间存在差异,部分原因是缺乏最新的、全面的预防和治疗方案。此外,很少有尝试审查脊柱侧凸手术后 SSI 的最佳诊断方式和治疗策略。本研究的目的是系统回顾小儿脊柱侧凸手术患者 SSI 的危险因素,以及预防、诊断和治疗策略的现有文献。
2022 年 1 月 19 日,根据《系统评价和荟萃分析的首选报告项目》(PRISMA)指南进行了系统评价。纳入报告急性、深部 SSI(<90d)风险因素或预防、诊断或治疗小儿脊柱侧凸手术后 SSI 策略的研究。根据研究设计和质量,对每个纳入的文章进行证据水平评级。提取的发现被组织成危险因素、预防策略、诊断方式和治疗选择,根据证据的质量、数量和数据基础的一致性对每一项进行分级。
共有 77 项研究符合纳入标准,并纳入本系统评价,其中 2 项被归类为 I 级,3 项为 II 级,64 项为 III 级,8 项为 IV 级。从这些研究中,总共综合了 29 项关于 SSI 危险因素、预防、诊断或治疗的证据(C 级或更高)。
我们对小儿脊柱侧凸手术后定义高危患者以及预防、诊断和治疗 SSI 的已发表证据进行了更新综述。本文汇集的证据可能有助于限制实践中的变异性并降低小儿脊柱手术中 SSI 的发生率。
III 级-系统评价。